Cargando…
Anti-Angiogenic Effect of Asperchalasine A Via Attenuation of VEGF Signaling
Cytochalasans are a group of structurally diverse fungal polyketide-amino acid hybrid metabolites that exhibit diverse biological functions. Asperchalasine A was identified and isolated from an extract of the marine-derived fungus, Aspergillus. Asperchalasine A is a cytochalasan dimer which consists...
Autores principales: | Park, Jun Yeon, Ji, Young Seok, Zhu, Hucheng, Zhang, Yonghui, Park, Do Hwi, Kim, Young-Joo, Yoo, Hye Hyun, Kang, Ki Sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722956/ https://www.ncbi.nlm.nih.gov/pubmed/31408989 http://dx.doi.org/10.3390/biom9080358 |
Ejemplares similares
-
Anti-angiogenic alternatives to VEGF blockade
por: Khan, Kabir A., et al.
Publicado: (2015) -
Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme
por: Kang, Wonyoung, et al.
Publicado: (2015) -
Anti-Angiogenic Property of Free Human Oligosaccharides
por: Bae, Boram, et al.
Publicado: (2021) -
Preclinical Efficacy and Safety of VEGF-Grab, a Novel Anti-VEGF Drug, and Its Comparison to Aflibercept
por: Hong, Hye Kyoung, et al.
Publicado: (2020) -
Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway
por: Itatani, Yoshiro, et al.
Publicado: (2018)